Role of the PPARα Leu162Val and PPARγ2 Pro12Ala gene polymorphisms in weight change after 2.5-year follow-up in Czech obese women

Folia Biologica

Volumn 56, Issue 3, 2010, Pages 116-123

  Aldhoon, Bashar ^a,b   Zamrazilova H ^b   Aldhoon Hainerova I ^c   Sramkova P ^b,d   Spalova J ^b   Kunesova M ^b   Bendlova B ^b   Hainer, V ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Obesity Management Unit of the Clinical Centre ISCARE IVF   (Czech Republic)

Author keywords

Body mass index changes; Leu162Val polymorphism; Obesity; PPAR ; PPAR 2; Pro12Ala polymorphism; Psycho behavioural factors and genetics

Indexed keywords

ADIPONECTIN; GHRELIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALLELE; ARTICLE; BECK DEPRESSION INVENTORY; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CZECH REPUBLIC; DEPRESSION; DIET RESTRICTION; DNA POLYMORPHISM; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUNGER; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; OBESITY; PHYSICAL ACTIVITY; STRUCTURED QUESTIONNAIRE; THREE FACTOR EATING QUESTIONNAIRE; WAIST HIP RATIO; WEIGHT CHANGE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CZECH REPUBLIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR ALPHA; PPAR GAMMA;

EID: 77954392609     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M. C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., Tuomi, T., Gaudet, D., Hudson, T. J., Daly, M., Groop, L., Lander, E. S. (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26, 76-80.
2. Auwerx, J. (1999) PPARγ, the ultimate thrifty gene. Diabetologia 42, 1033-1049.
3. Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., Shuldiner, A. R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47, 1806-1808.
4. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., Erbaugh, J. (1961) An inventory for measuring depression. Arch. Gen. Psychiatry 4, 561-571.
5. Bendlova, B., Vejrazkova, D., Vcelak, J., Lukasova, P., Burkonova, D., Kunesova, M., Vrbikova, J., Dvorakova, K., Vondra, K., Vankova, M. (2008) PPARγ2 Pro12Ala polymorphism in relation to free fatty acids concentration and composition in lean healthy Czech individuals with and without family history of diabetes type 2. Physiol. Res. 57, 77-90.
6. Bosse, Y., Despres, J. P., Bouchard, C., Perusse, L., Vohl, M. C. (2003) The peroxisome proliferator-activated receptor α L162V mutation is associated with reduced adiposity. Obes. Res. 11, 809-816.
7. Bouchard, L., Drapeau, V., Provencher, V., Lemieux, S., Chagnon, Y., Rice, T., Rao, D. C., Vohl, M. C., Tremblay, A., Bouchard, C., Perusse, L. (2004) Neuromedin β: a strong candidate gene linking eating behaviors and susceptibility to obesity. Am. J. Clin. Nutr. 80, 1478-1486.
8. Boutin, P., Dina, C., Vasseur, F., Dubois, S., Corset, L., Seron, K., Bekris, L., Cabellon, J., Neve, B., Vasseur-Delannoy, V., Chikri, M., Charles, M. A., Clement, K., Lernmark, A., Froguel, P. (2003) GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol. 1, E68.
9. Bryant, E. J., King, N. A., Blundell, J. E. (2008) Disinhibition: its effects on appetite and weight regulation. Obes. Rev. 9, 409-419.
10. Comings, D. E., Gade, R., MacMurray, J. P., Muhleman, D., Peters, W. R. (1996) Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol. Psychiatry 1, 325-335. (Pubitemid 126441317)
11. Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W. Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20, 284-287.
12. Desvergne, B., Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20, 649-688.
13. Ek, J., Urhammer, S.A., Sorensen, T. I., Andersen, T., Auwerx, J., Pedersen, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-γ2 (PPAR-γ2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42, 892-895.
14. Evans, D., Aberle, J., Wendt, D., Wolf, A., Beisiegel, U., Mann, W. A. (2001) A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J. Mol. Med. 79, 198-204.
15. Fuemmeler, B. F., Agurs-Collins, T., McClemon, F. J., Kollins, S. H., Garrett, M. E., Ashley-Koch, A. E. (2009) Interactions between genotype and depressive symptoms on obesity. Behav. Genet. 39, 296-305.
16. Gonzalez Sanchez, J. L., Serrano Rios, M., Fernandez Perez, C., Laakso, M., Martinez Larrad, M. T. (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur. J. Endocrinol. 147, 495-501.
17. Gouni-Berthold, I., Giannakidou, E., Muller-Wieland, D., Faust, M., Kotzka, J., Berthold, H. K., Krone, W. (2004) Association between the PPARα L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls. Am. Heart J. 147, 1117-1124.
18. Goyenechea, E., Dolores Parra, M., Alfredo Martinez, J. (2006) Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-γ2 gene polymorphisms. Br. J. Nutr. 96, 965-972.
19. Hainer, V., Kunesova, M., Bellisle, F., Hill, M., Braunerova, R., Wagenknecht, M. (2005) Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine. Int. J. Obes. 29, 208-216.
20. Hainer, V., Zamrazilova, H., Spalova, J., Hainerova, I., Kunesova, M., Aldhoon, B., Bendlova, B. (2008) Role of hereditary factors in weight loss and its maintenance. Physiol. Res. 57, 1-15.
21. Kapoor, M., Kapur, S., Mehra, S., Dube, U., Sharad, S., Sidhu, S. (2009) Genetic variation in D7S1875 repeat polymorphism of leptin gene is associated with increased risk for depression: a case-control study from India. Depress. Anxiety 26, 791-795.
22. Krishnamurthy, P., Romagni, P., Torvik, S., Gold, P. W., Charney, D. S., Detera-Wadleigh, S., Cizza, G. (2008) Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. Horm. Metab. Res. 40, 194-198.
23. Lindi, V. I., Sivenius, K., Niskanen, L., Laakso, M., Uusitupa, M. I. (2001) Effect of the Pro12Ala polymorphism of the PPAR-γ2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 44, 925-926.
24. Lindi, V. I., Uusitupa, M. I., Lindstrom, J., Louheranta, A., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Tuomilehto, J. (2002) Association of the Pro12Ala polymorphism in the PPAR-γ2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51, 2581-2586.
25. Luan, J., Browne, P. O., Harding, A. H., Halsall, D. J., O'Rahilly, S., Chatterjee, V. K., Wareham, N. J. (2001) Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 50, 686-689. (Pubitemid 32195237)
26. Malecki, M. T., Frey, J., Klupa, T., Skupien, J., Walus, M., Mlynarski, W., Sieradzki, J. (2003) The Pro12Ala polymorphism of PPARγ2 gene and susceptibility to type 2 diabetes mellitus in a Polish population. Diabetes Res. Clin. Pract. 62, 105-11
27. Marti, A., Moreno-Aliaga, M. J., Hebebrand, J., Martinez, J. A. (2004) Genes, lifestyles and obesity. Int. J. Obes. Relat. Metab. Disord. 28, 29-36.
28. Masud, S., Ye, S. (2003) Effect of the peroxisome proliferator activated receptor-γ gene Pro12Ala variant on body mass index: a meta-analysis. J. Med. Genet. 40, 773-780.
29. Meirhaeghe, A., Amouyel, P. (2004) Impact of genetic variation of PPARγ in humans. Mol. Genet. Metab. 83, 93-102.
30. Meirhaeghe, A., Corel, D., Amouyel, P., Dallongeville, J. (2005) Association between peroxisome proliferator-activated receptor γ haplotypes and the metabolic syndrome in French men and women. Diabetes 54, 3043-3048.
31. Montagnana, M., Fava, C., Nilsson, P. M., Engstrom, G., Hedblad, B., Lippi, G., Minuz, P., Berglund, G., Melander, O. (2008) The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals. Diabet. Med. 25, 902-908.
32. Morini, E., Tassi, V., Capponi, D., Ludovico, O., Dallapiccola, B., Trischitta, V., Prudente, S. (2008) Interaction between PPARγ2 variants and gender on the modulation of body weight. Obesity 16, 1467-1470.
33. Neale, B. M., Mazzeo, S. E., Bulik, C. M. (2003) A twin study of dietary restraint, disinhibition and hunger: an examination of the eating inventory (three-factor eating questionnaire). Twin Res. 6, 471-478.
34. Nicklas, B. J., van Rossum, E. F., Berman, D. M., Ryan, A. S., Dennis, K. E., Shuldiner, A. R. (2001) Genetic variation in the peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 50, 2172-2176.
35. Nielsen, E. M., Hansen, L., Echwald, S. M., Drivsholm, T., Borch-Johnsen, K., Ekstrom, C. T., Hansen, T., Pedersen, O. (2003) Evidence for an association between the Leu162Val polymorphism of the PPARα gene and decreased fasting serum triglyceride levels in glucose tolerant subjects. Pharmacogenetics 13, 417-423.
36. Pinterova, D., Cerna, M., Kolostova, K., Novota, P., Cimburova, M., Romzova, M., Kubena, A., Andel, M. (2004) The frequency of alleles of the Pro12Ala polymorphism in PPARγ2 is different between healthy controls and patients with type 2 diabetes. Folia Biol. (Praha) 50, 153-156.
37. Robitaille, J., Brouillette, C., Houde, A., Lemieux, S., Perusse, L., Tchernof, A., Gaudet, D., Vohl, M.C. (2004) Association between the PPARα-L162V polymorphism and components of the metabolic syndrome. J. Hum. Genet. 49, 482-489.
38. Rosmond, R., Chagnon, M., Bouchard, C. (2003) The Pro12Ala PPARγ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab. Res. Rev. 19, 159-63.
39. Sesti, G., Perego, L., Cardellini, M., Andreozzi, F., Ricasoli, C., Vedani, P., Guzzi, V., Marchi, M., Paganelli, M., Ferla, G., Pontiroli, A. E., Hribal, M. L., Folli, F. (2005) Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J. Clin. Endocrinol. Metab. 90, 5064-5069.
40. Skogsberg, J., Kannisto, K., Cassel, T. N., Hamsten, A., Eriksson, P., Ehrenborg, E. (2003) Evidence that peroxisome proliferator-activated receptor δ influences cholesterol metabolism in men. Arterioscler. Thromb. Vase. Biol. 23, 637-643.
41. Sparso, T., Hussain, M. S., Andersen, G., Hainerova, I., Borch-Johansen, K., Jorgensen, T., Hansen, T., Pedersen, O. (2007) Relationships between the functional PPARα Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people. Mol. Genet. Metab. 90, 205-209.
42. Sramkova, D., Kunesova, M., Hainer, V., Hill, M., Vcelak, J., Bendlova, B. (2002) Is a Pro12Ala polymorphism of the PPARγ2 gene related to obesity and type 2 diabetes mellitus in the Czech population? Ann. N. Y. Acad. Sci. 967, 265-273.
43. Steinle, N. I., Hsueh, W. C., Snitker, S., Pollin, T. I., Sakul, H., St Jean, P. L., Bell, C. J., Mitchell, B. D., Shuldiner, A. R. (2002) Eating behavior in the Old Order Amish: heritability analysis and a genome-wide linkage analysis. Am. J. Clin. Nutr. 75, 1098-1106.
44. Stumvoll, M., Haring, H. (2002) The peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism. Diabetes 51, 2341-2347. (Pubitemid 34827380)
45. Stunkard, A. J., Messick, S. (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J. Psychosom. Res. 29, 71-83.
46. Tai, E. S., Demissie, S., Cupples, L. A., Corella, D., Wilson, P. W., Schaefer, E. J., Ordovas, J. M. (2002) Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 22, 805-810.
47. Uthurralt, J., Gordish-Dressman, H., Bradbury, M., Tesi-Rocha, C., Devaney, J., Harmon, B., Reeves, E. K., Brandoli, C., Hansen, B. C., Seip, R. L., Thompson, P. D., Price, T. B., Angelopoulos, T. J., Clarkson, P. M., Moyna, N. M., Pescatello, L. S., Visich, P. S., Zoeller, R. F., Gordon, P. M., Hoffman, E. P. (2007) PPARα L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males. BMC Med. Genet. 8, 55.
48. Valve, R., Sivenius, K., Miettinen, R., Pihlajamaki, J., Rissanen, A., Deeb, S. S., Auwerx, J., Uusitupa, M., Laakso, M. (1999) Two polymorphisms in the peroxisome proliferator-activated receptor-γ gene are associated with severe overweight among obese women. J. Clin. Endocrinol. Metab. 84, 3708-3712.
49. Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J., Caro, J. F., Flier, J. S. (1997) Peroxisome proliferator- activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest. 99, 2416-2422.
50. Vogels, N., Mariman, E. C., Bouwman, F. G., Kester, A. D., Diepvens, K., Westerterp-Plantenga, M. S. (2005) Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor γ2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am. J. Clin. Nutr. 82, 740-746.
51. Vohl, M. C., Lepage, P., Gaudet, D., Brewer, C. G., Betard, C., Perron, P., Houde, G., Cellier, C., Faith, J. M., Despres, J. P., Morgan, K., Hudson, T. J. (2000) Molecular scanning of the human PPARα gene: association of the L162v mutation with hyperapobetalipoproteinemia. J. Lipid. Res. 41, 945-952.
52. Zietz, B., Barth, N., Spiegel, D., Schmitz, G., Scholmerich, J., Schaffler, A. (2002) Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 (PPARγ2) is associated with higher levels of total cholesterol and LDL-cholesterol in male Caucasian type 2 diabetes patients. Exp. Clin. Endocrinol. Diabetes 110, 60-66.